Introduction: Despite the rise of direct oral anticoagulants (DOACs), vitamin K antagonists
(VKA) remain the most widely used oral anticoagulants in developing countries. The aim of …

Vitamin K antagonists (VKA) is the primary anticoagulant in most settings of Sub-Saharan
Africa. Understanding the quality of anticoagulation services in the continent is vital in …

Background Given that vitamin K-dependent anticoagulants (VKAs) will continue to be the
primary anticoagulant in Africa for a long time, understanding the quality of anticoagulation …

Introduction: les antivitamines K (AVK), traitement anticoagulant oral le plus largement
prescrit, posent un réel problème de santé publique du fait de leur risque iatrogène …

Background Given that vitamin K-dependent anticoagulants (VKAs) will continue to be the
primary anticoagulant in Africa for a long time, understanding the quality of anticoagulation …

Background: Since the approval of warfarin, a Vitamin K antagonist anticoagulant (VKA), no
other oral anticoagulant existed for patients who needed long‑term anticoagulation therapy …

Methods It is an observational study, carried out between November 2015 and November
30, 2016. The international normalized ratio (INR) values were prospectively obtained, and …

Introduction Anticoagulant therapy is an effective measure in preventing thromboembolic
adverse events. Of the diseases in which this treatment is indicated, atrial fibrillation (AF) has …

Background: Vitamin K antagonists (VKAs) remain the mainstay of anticoagulation therapy,
which requires monitoring of international normalised ratio (INR). Quality of oral …

Background: Even with the introduction of direct oral anticoagulants (DOACs),
anticoagulation clinics (ACs) stand with a key role in monitoring. Indeed, routine evaluation …